What Next After Early End of MOSAICO HIV Vaccine Trial? Main focus now will be approaches using broadly neutralizing HIV-1 antibodies, researchers say Feb 24, 2023
Long-Acting Injectable HIV Regimen on Par With Daily Drugs Trial shows noninferiority to daily antiretroviral pills for controlling HIV Feb 23, 2023
Severe Mpox in Advanced HIV Patients Tied to Complications, Death Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing Feb 23, 2023
Children's HIV Deaths in Africa Largely Preventable Half of kids under age 5 not diagnosed before death, CHAMPS study found Feb 22, 2023
Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists Substudy of HPTN 083 trial examined differences in outcomes by race among U.S. participants Feb 22, 2023
Doxycycline Fails to Protect Women Against STIs Trial results came as a surprise after success in prophylaxis for other groups Feb 21, 2023
Sutezolid With 3-Drug Combo Appears Safe and Effective in Multidrug-Resistant TB Sutezolid may be a replacement for linezolid in these patients, researcher says Feb 21, 2023
For People With HIV, Early Anal Cancer Screening Tied to Better Outcomes All people with HIV should be screened, not just men who have sex with men, researchers say Jan 13, 2023
Long-Acting HIV Drug Promising for Treatment-Naive Patients Phase II results move field closer to twice-yearly dosing, although ART options remain a hurdle Jan 09, 2023
Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity Also in TTHealthWatch: sodium levels and health outcomes Jan 07, 2023 podcast
Life Lessons From Death A conversation with best-selling author and renowned Buddhist teacher Frank Ostaseski Dec 20, 2022 podcast
Tony Fauci's True Legacy As he steps down, I'd like to recognize his enduring commitment to explaining complicated science Dec 19, 2022
Start HIV Antiretroviral Therapy ASAP, Experts Urge Higher risk of death, serious health issues with delayed therapy, data from START trial suggest Oct 25, 2022
Extra Hep B Vaccine Dose Exceeds Expectations for People With HIV Seroprotection seen in 100% of participants after three doses of Heplisav-B vaccine Oct 23, 2022
Engaging in Healthcare May Close Longevity Gap Between Black and White Men With HIV Starting with HIV testing, men who have sex with men could see gains in life expectancy Oct 21, 2022
More Harm Reduction, Less Abstinence-Only in COVID Messaging, Experts Say "We know that abstinence-only doesn't work in any situation" Oct 12, 2022
CDC Warns of Severe Monkeypox in People With HIV, the Immunocompromised Reports of myocarditis, penile necrosis, and atypical/persistent rash requiring amputation Sep 30, 2022
First-Line HIV Treatment Proves Mettle in Pregnant Patients Dolutegravir linked with better viral suppression versus other ART regimens Aug 31, 2022
Monkeypox Detected in Asymptomatic Men The virus was found on anal swabs collected for routine STI testing Aug 16, 2022
Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections Head-to-head comparison in ALLIANCE trial favors use over dolutegravir-based combination Aug 03, 2022
Dual Therapy Holds Its Own in Treatment-Naive HIV ANDES study shows less expensive therapy to be a "safe and well-tolerated" option Aug 02, 2022
Symposium on Monkeypox Stigma Interrupted by Protesters International experts advocate for accurate, timely information, while minimizing discrimination Aug 02, 2022
Activists Crash AIDS Meeting, Protest for Better Access to Antiretrovirals Demonstrators used their time at the convention center to endorse the "U = U" message Aug 01, 2022
People With Advanced AIDS Benefit From Dolutegravir Treatment Trial in Brazil offers hope for "late-presenter HIV patients" Jul 31, 2022
Durable Long-term Results With Dolutegravir for HIV Suppression SIMPL'HIV and NAMSAL trial data support WHO backing of dolutegravir, expert says Jul 31, 2022
Two More Patients With HIV Surviving Without Antiretrovirals Functional cures now seen in 5 patients Jul 29, 2022
Post-Exposure Doxycycline Reduces STIs Incidence of gonorrhea, chlamydia, and syphilis more than halved Jul 29, 2022
Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
German Study Warns of Increasing Acute Hep C Reinfections in MSM 14% of patients experienced a reinfection over the past decade Jun 24, 2022
Early Anal Lesion Treatment Cuts Cancer Risk in People With HIV ANCHOR data support screening and treatment for anal HSIL in those ages 35 and up Jun 15, 2022
Simpler Antifungal Course Works for Cryptococcal Meningitis in Africa Single high-dose antifungal-based regimen non-inferior to standard WHO-recommended treatment Mar 23, 2022
Advocates to Government: 'Go Big' on HIV Prevention Efforts Overhaul needed to improve access and cost after systemic failures, experts say Mar 16, 2022
FDA Greenlights First Condom Specifically for Anal Intercourse One Male Condom turned in less than 1% total condom failure rate Feb 23, 2022
HIV Self-Tests Reached High-Risk Populations CDC researchers found a substantial minority of patients had never been tested Feb 18, 2022
Ablating High-Grade Anal Lesions Thwarts Progression to Cancer Screening followed by aggressive therapy shows benefit in phase III ANCHOR study Feb 17, 2022
COVID Makes Everything Worse in Pregnancy And those with HIV experienced the worst outcomes Feb 17, 2022
Young Women Prefer Vaginal Ring as HIV Prevention But oral pre-exposure prophylaxis also gets support, study in Africa finds Feb 17, 2022
ART-Free Strategy Could Control HIV in Some African Kids Broadly neutralizing antibodies show promise in proof-of-concept study in Botswana Feb 16, 2022
Third Person 'Cured' of HIV via Transplant U.S. woman with leukemia gets cord blood resistant to HIV Feb 16, 2022
U.S. Sees Drop in Lifetime Risk of HIV Diagnosis One of every 120 Americans will be diagnosed with HIV in their lifetime, analysis suggests Feb 15, 2022
